Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia
Back to article page
OriginalPaper|Updated:2021-08-27
|
Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia
Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia
中国结合医学杂志(英文版)1997年3卷第3期 页码:191-194
Affiliations:
1. Mental Health Institute, Beijing Medical University,Beijing
Luo, Hc., Shen, Yc., Yu, X. et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia., CJIM 3, 191–194 (1997). https://doi.org/10.1007/BF02935137
He-chun Luo, Yu-cun Shen, Xin Yu, et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia[J]. Chinese Journal of Integrative Medicine, 1997,3(3):191-194.
Luo, Hc., Shen, Yc., Yu, X. et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia., CJIM 3, 191–194 (1997). https://doi.org/10.1007/BF02935137DOI:
He-chun Luo, Yu-cun Shen, Xin Yu, et al. Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia[J]. Chinese Journal of Integrative Medicine, 1997,3(3):191-194. DOI: 10.1007/BF02935137.
Clinical study on Shuxuening combined with antipsychotics in treating chronic schizophreniacombined with antipsychotics in treating chronic schizophrenia
摘要
Objective: To make a preliminary evaluation of the clinical efficacy of Shuxuening (SXN).Methods: One hundred and forty-nine chronic schizophrenic patients were divided randomly into the SXN group and the control group in a double-blind research. SXN was given to the SXN group and placebo to the control group
and patients of both groups went on receiving the previous antipsychotic treatment. Brief Psychiatric Rating Scale (BPRS)
Scale for Assessment of Negative Symptoms (SANS) and Treatment Emergent Symptoms Scale (TESS) were used to assess the effects of treatment and side effects of the drug. The evaluation was done before and during the 2nd
4th
6th
10th and 12 th weeks in the course of treatment.Results: SXN was effective by BPRS evaluation (P < 0.05)
and even the more effective to negative symptoms than positive symptoms by SANS evaluation (P < 0.05). It was safe and with little side effect. In addition
it was found that the incipience of SXN’ s efficacy was somehow related with the course of disease and the daily dosage used.Conclusion: SXN is worthy of further study n the treatment of chronic schizophrenia.
Abstract
Objective: To make a preliminary evaluation of the clinical efficacy of Shuxuening (SXN).Methods: One hundred and forty-nine chronic schizophrenic patients were divided randomly into the SXN group and the control group in a double-blind research. SXN was given to the SXN group and placebo to the control group
and patients of both groups went on receiving the previous antipsychotic treatment. Brief Psychiatric Rating Scale (BPRS)
Scale for Assessment of Negative Symptoms (SANS) and Treatment Emergent Symptoms Scale (TESS) were used to assess the effects of treatment and side effects of the drug. The evaluation was done before and during the 2nd
4th
6th
10th and 12 th weeks in the course of treatment.Results: SXN was effective by BPRS evaluation (P < 0.05)
and even the more effective to negative symptoms than positive symptoms by SANS evaluation (P < 0.05). It was safe and with little side effect. In addition
it was found that the incipience of SXN’ s efficacy was somehow related with the course of disease and the daily dosage used.Conclusion: SXN is worthy of further study n the treatment of chronic schizophrenia.
关键词
chronic schizophreniaflavonesShuxuening
Keywords
chronic schizophreniaflavonesShuxuening
references
3 1994; 597–598.
1991, 10: 331.
Defeudis FV. Ginkgo biloba extract (EGb 761):Pharmacological activities and clnical applications. Paris Elcevier, 1991.
Pacher L, Prilipko L, Christer Y. Free radical in the brain: aging, neurological and mental disorders. Berlin Springer-Verlag, 1992.
Prilipko L. Free radicals in the brain: aging, neurological and mental disorders. Berlin Springer-Verlag, 1992.